Cross Country Healthcare, Inc. to Post Q1 2018 Earnings of $0.10 Per Share, Oppenheimer Forecasts (CCRN)
Cross Country Healthcare, Inc. (NASDAQ:CCRN) – Stock analysts at Oppenheimer decreased their Q1 2018 earnings per share estimates for shares of Cross Country Healthcare in a research note issued to investors on Tuesday. Oppenheimer analyst M. Wiederhorn now expects that the business services provider will post earnings per share of $0.10 for the quarter, down from their prior forecast of $0.12. Oppenheimer also issued estimates for Cross Country Healthcare’s Q2 2018 earnings at $0.18 EPS, Q3 2018 earnings at $0.23 EPS, FY2018 earnings at $0.76 EPS, Q1 2019 earnings at $0.12 EPS, Q2 2019 earnings at $0.21 EPS, Q3 2019 earnings at $0.25 EPS, Q4 2019 earnings at $0.27 EPS and FY2019 earnings at $0.85 EPS.
Cross Country Healthcare (NASDAQ:CCRN) last posted its earnings results on Wednesday, November 1st. The business services provider reported $0.23 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.18 by $0.05. Cross Country Healthcare had a net margin of 0.19% and a return on equity of 11.69%. The firm had revenue of $228.50 million during the quarter, compared to analysts’ expectations of $228.97 million. During the same period last year, the company posted $0.24 EPS. The company’s quarterly revenue was up 6.3% compared to the same quarter last year.
Cross Country Healthcare (CCRN) traded down $0.05 during trading hours on Wednesday, hitting $12.89. 225,400 shares of the stock traded hands, compared to its average volume of 199,908. Cross Country Healthcare has a 12-month low of $11.07 and a 12-month high of $16.38. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.14 and a current ratio of 2.14. The stock has a market cap of $470.41, a PE ratio of 644.50, a price-to-earnings-growth ratio of 1.72 and a beta of 0.75.
A number of large investors have recently added to or reduced their stakes in CCRN. Alliancebernstein L.P. grew its stake in shares of Cross Country Healthcare by 8.7% in the second quarter. Alliancebernstein L.P. now owns 40,095 shares of the business services provider’s stock worth $518,000 after acquiring an additional 3,200 shares during the period. Benefit Street Partners LLC grew its stake in shares of Cross Country Healthcare by 30.9% in the second quarter. Benefit Street Partners LLC now owns 1,544,440 shares of the business services provider’s stock worth $19,939,000 after acquiring an additional 364,229 shares during the period. Schwab Charles Investment Management Inc. grew its stake in shares of Cross Country Healthcare by 20.7% in the second quarter. Schwab Charles Investment Management Inc. now owns 75,215 shares of the business services provider’s stock worth $972,000 after acquiring an additional 12,900 shares during the period. BNP Paribas Arbitrage SA grew its stake in shares of Cross Country Healthcare by 85.0% in the third quarter. BNP Paribas Arbitrage SA now owns 18,500 shares of the business services provider’s stock worth $263,000 after acquiring an additional 8,502 shares during the period. Finally, Highbridge Capital Management LLC bought a new stake in shares of Cross Country Healthcare in the third quarter worth approximately $402,000. Institutional investors and hedge funds own 92.08% of the company’s stock.
In other Cross Country Healthcare news, General Counsel Susan E. Ball sold 25,000 shares of the firm’s stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $14.19, for a total transaction of $354,750.00. Following the completion of the sale, the general counsel now directly owns 126,921 shares in the company, valued at approximately $1,801,008.99. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Thomas C. Dircks acquired 10,000 shares of Cross Country Healthcare stock in a transaction on Monday, November 6th. The shares were purchased at an average price of $11.77 per share, with a total value of $117,700.00. Following the completion of the purchase, the director now owns 104,571 shares in the company, valued at approximately $1,230,800.67. The disclosure for this purchase can be found here. Company insiders own 3.90% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This piece of content was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://theolympiareport.com/2018/01/19/cross-country-healthcare-inc-to-post-q1-2018-earnings-of-0-10-per-share-oppenheimer-forecasts-ccrn.html.
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.